Board change at biotech firm (From Oxford Mail)
Get involved: send your photos, videos, news & views by texting OXFORD NEWS to 80360 or email us
Board change at biotech firm
11:10am Saturday 11th February 2012 in News
Andrew Wood has stepped down from the board of biotech firm Oxford Biomedica, where he was chief financial officer.
Tim Watts has been appointed to the board as chief financial officer and company secretary, with Mr Wood – who has worked for the firm since 1996 – staying as an employee to ensure a smooth transition.
Mr Watts is a senior financial executive with more than 30 years’ experience in the industry, most recently as chief financial officer at Archimedes Pharma.
Comments(2)
Andrew:Oxford
says...
1:07pm Sat 11 Feb 12
Darkforbid wrote:My average is 15p per share, they peaked at 55p per share and now sitting at 3p per share.
┄Oxford BioMedica (LSE: OXB) is a
biopharmaceutical company
specializing in the development
and commercialization of
innovative gene-based medicines.
It was established in 1995 as a
spin out from Oxford University.┄
This business needs a good product and soon..
Can't say I'm overly impressed with the performance.
Hey, ho. If I dispose of them can offset the loss against a gain.
Darkforbid says...
11:38am Sat 11 Feb 12
biopharmaceutical company
specializing in the development
and commercialization of
innovative gene-based medicines.
It was established in 1995 as a
spin out from Oxford University.┄
This business needs a good product and soon..